Jain Global LLC Cuts Boston Scientific Stock Holdings

Investment firm reduces stake in medical device company by over 70%

Mar. 17, 2026 at 9:35am

Got story updates? Submit your updates here. ›

Jain Global LLC, a major investor, has significantly reduced its stake in Boston Scientific Corporation, a leading medical equipment provider. The fund sold off over 153,000 shares of Boston Scientific stock during the third quarter, lowering its overall holdings by 70.5%. Jain Global now owns 64,205 shares of Boston Scientific, valued at around $6.27 million.

Why it matters

This move by a major institutional investor highlights the volatility and uncertainty surrounding Boston Scientific's stock performance. As a prominent medical device company, Boston Scientific's financial health is closely watched by the investment community. Jain Global's decision to substantially trim its position could signal broader concerns about the company's outlook or the overall medical technology sector.

The details

According to a recent filing with the Securities and Exchange Commission, Jain Global LLC reduced its stake in Boston Scientific Corporation by 70.5% during the third quarter. The fund sold 153,230 shares, leaving it with 64,205 shares worth approximately $6.27 million. Boston Scientific is a leading manufacturer of medical devices and equipment used in various procedures, including cardiovascular, digestive, and chronic pain treatments.

  • Jain Global LLC made the stock sale during the 3rd quarter of the year.

The players

Jain Global LLC

An investment management firm that has reduced its stake in Boston Scientific Corporation by over 70%.

Boston Scientific Corporation

A major medical device company that develops and markets a broad portfolio of products used in less-invasive medical procedures.

Got photos? Submit your photos here. ›

The takeaway

Jain Global's substantial reduction in its Boston Scientific holdings suggests potential concerns about the company's near-term prospects or the broader medical technology industry. This move by a major investor could foreshadow further volatility in Boston Scientific's stock price and merits close monitoring by shareholders and industry analysts.